Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancerPérez Carrión, R ; Alberola Candel, V ; Calabresi, F ; Michel, R T ; Santos, R ; Delozier, T ; Goss, P ; Mauriac, L ; Feuilhade, F ; Freue, MAnnals of oncology, 1994, Vol.5 Suppl 7, p.S19-S24 [Periódico revisado por pares]EnglandTexto completo disponível |
|
2 |
Material Type: Artigo
|
Controlled Clinical Study on the Use of Dichloromethylene Diphosphonate in Patients with Breast Carcinoma Metastasizing to the SkeletonMartoni, Andrea ; Guaraldi, Monica ; Camera, Paolo ; Biagi, Renato ; Marri, Susanna ; Beghé, Franco ; Pannuti, FrancoOncology, 1991, Vol.48 (2), p.97-101 [Periódico revisado por pares]Basel, Switzerland: KargerSem texto completo |
|
3 |
Material Type: Artigo
|
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study GroupNabholtz, J M ; Senn, H J ; Bezwoda, W R ; Melnychuk, D ; Deschênes, L ; Douma, J ; Vandenberg, T A ; Rapoport, B ; Rosso, R ; Trillet-Lenoir, V ; Drbal, J ; Molino, A ; Nortier, J W ; Richel, D J ; Nagykalnai, T ; Siedlecki, P ; Wilking, N ; Genot, J Y ; Hupperets, P S ; Pannuti, F ; Skarlos, D ; Tomiak, E M ; Murawsky, M ; Alakl, M ; Aapro, MJournal of clinical oncology, 1999-05, Vol.17 (5), p.1413 [Periódico revisado por pares]United StatesSem texto completo |
|
4 |
Material Type: Artigo
|
Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II studyPedrazzoli, P ; Zamagni, C ; Martoni, A ; Capotorto, A M ; Da Prada, G A ; Pavesi, L ; Preti, P ; Lelli, G ; Pannuti, F ; Robustelli della Cuna, GTumori, 1994-08, Vol.80 (4), p.273-275 [Periódico revisado por pares]United StatesSem texto completo |
|
5 |
Material Type: Artigo
|
Comparative Phase II Study of Idarubicin versus Doxorubicin in Advanced Breast CancerMartoni, Andrea ; Piana, Edera ; Guaraldi, Monica ; Cilenti, Giuseppina ; Farris, Antonio ; Saccani, Ferruccio ; Becchi, Giorgio ; Pannuti, FrancoOncology, 1990, Vol.47 (5), p.427-432 [Periódico revisado por pares]Basel, SwitzerlandSem texto completo |
|
6 |
Material Type: Artigo
|
Aminoglutethimide in advanced breast cancer plasma levels and clinical results after low and high dosesSTROCCHI, E ; CAMAGGI, C. M ; BICHISAO, E ; ROBUSTELLI DELLA CUNA, G ; PANNUTI, F ; MARTONI, A ; CELLERINO, R ; MISERIA, S ; MALACARNE, P ; INDELLI, M ; BALLI, M ; BONCIARELLI, G ; AMBROSO, GCancer chemotherapy and pharmacology, 1991-01, Vol.27 (6), p.451-455 [Periódico revisado por pares]Berlin: SpringerTexto completo disponível |
|
7 |
Material Type: Artigo
|
5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC Combination) in Advanced Breast CancerZamagni, C. ; Martoni, A. ; Ercolino, L. ; Baroni, M. ; Tanneberger, S. ; Pannuti, F.Journal of chemotherapy (Florence), 1991-04, Vol.3 (2), p.126-129 [Periódico revisado por pares]Firenze: Taylor & FrancisSem texto completo |
|
8 |
Material Type: Artigo
|
Aminoglutethimide in advanced breast cancer: prospective, randomized comparison of two dose levels. Italian Cooperative GroupRobustelli della Cuna, G ; Pannuti, F ; Martoni, A ; Camaggi, C M ; Strocchi, E ; Da Prada, G A ; Tanneberger, SAnticancer research, 1993-11, Vol.13 (6B), p.2367 [Periódico revisado por pares]GreeceSem texto completo |
|
9 |
Material Type: Artigo
|
The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot studyMartoni, A ; Pacciarini, M A ; Pannuti, FDrugs under experimental and clinical research, 1985, Vol.11 (2), p.127 [Periódico revisado por pares]SwitzerlandSem texto completo |
|
10 |
Material Type: Artigo
|
Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancerMartoni, Andrea ; Pacciarini, Maria Adele ; Pannuti, FrancoEuropean journal of cancer & clinical oncology, 1985-07, Vol.21 (7), p.803-806Oxford: Elsevier LtdTexto completo disponível |